Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement for Branded Medicines - National

NHS England

This public procurement record has 2 releases in its history.

AwardUpdate

09 Aug 2019 at 15:57

Award Notice
Award

07 Aug 2019 at 15:33

Award Notice
Summary of the contracting process

The NHS England is procuring a framework agreement titled "NHS Framework Agreement for Branded Medicines - National", classified under the pharmaceutical products industry. The procurement process, which is currently in the award stage, signifies a total value of £1.478 billion, covering the contract period from 1 May 2019 to 30 April 2021, with an option for a 24-month extension. The tender's deadline for submission of bids was on 17 January 2019, and the delivery addresses encompass various regions across the United Kingdom, including the North East, London, and the South West.

This tender presents a significant opportunity for businesses in the pharmaceutical and healthcare industries, particularly those capable of supplying branded medicines. A range of companies, including SMEs and larger pharmaceutical firms, are well-suited to compete for this contract given the diverse value chain involved in pharmaceutical distribution. With the NHS being a major buyer, this framework could enable suppliers to secure long-term contracts while contributing to public health outcomes across the UK.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement for Branded Medicines - National

Notice Description

NHS Framework Agreement for Branded Medicines - National Contract Period: 1 May 2019 to 30 April 2021 (with an option to extend for a period or periods of up 24 months) Tender Reference: CM/PHR/16/5518

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/166b70b9-418c-40ef-9712-5c4939822674
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (above threshold)
Tender Suitability
SME
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£1,478,000,000 £1B-£10B
Lots Value
Not specified
Awards Value
£1,351,341,890 £1B-£10B
Contracts Value
Not specified

Notice Dates

Publication Date
9 Aug 20197 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
1 May 20197 years ago
Contract Period
1 May 2019 - 30 Apr 2021 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
73
Supplier Names

AstraZeneca

Aventis Pharma ltd

Bayer Plc

B. Braun Medical Limited

Beaver Visitec International Sales Ltd

Biofrontera Pharma GmbH

Biogen Idec Ltd

Bristol Myers Squibb

CCMed Limited

Chiesi Limited

Cipla (EU) Ltd

Consilient Health Ltd

Crescent Pharma Limited

Desitin Pharma Ltd

Dexcel Pharma Ltd

Dr Falk Pharma UK Ltd

Drugsrus Ltd

Eisai Ltd

Eli Lilly & Company Ltd

Ennogen Healthcare Ltd

Ferndale Pharmaceuticals Ltd

Ferring Pharmaceuticals Ltd

FLYNN PHARMA LTD

Focus Pharmaceuticals Ltd

Gedeon Richter UK Ltd

Generics [UK] ta Mylan

Gilead Sciences Limited

GlaxoSmithKline UK Limited

Glenmark Pharmaceuticals Europe Ltd

Intrapharm Laboratories Ltd

Ipsen

Janssen-Cilag Ltd

Kent Pharmaceuticals Ltd

Kyowa Kirin Ltd

Almirall

Lupin Healthcare (UK) Limited

Martindale Pharma

medac Pharma LLP

Merck

Mercury Pharmaceuticals Limited

Morningside Pharmaceuticals Limited

Napp Pharmaceuticals Ltd

Neon Healthcare Ltd

Nordic Pharma

Norgine Pharmaceuticals Limited

Novartis Pharmaceuticals UK Ltd

Novo Nordisk

Parapharm Development Ltd

Pfizer Ltd

Pharmacosmos UK Ltd

Rayner Pharmaceuticals Ltd

RB Healthcare Ltd

Roche Products Ltd

Rosemont Pharmaceuticals Ltd

Sandoz Ltd

Selective Supplies Ltd

Thea Pharmaceuticals Limited

Takeda UK Ltd

Teva UK Limited

Tillomed Laboratories ltd

Tillotts Pharma UK Ltd

Torrent Pharma UK Ltd

Typharm Ltd

UCB Pharm Ltd

Zentiva Pharma UK Ltd

Abbvie Ltd

Accord-UK Ltd

Acre Pharma Limited

Aguettant Ltd

Alliance Pharmaceuticals Limited

Aspen Pharma Ireland Limited

Aspire Pharma Ltd

Genzyme Therapeutics Limited

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...